← Back to Rankings

CFGCitizens Financial Group, Inc.

Fundamentals Score: 43.2/100 (Weak Fundamentals) · Financial Services

Description

Citizens Financial Group, Inc. (CFG) functions as the holding company for Citizens Bank, National Association, a major financial institution offering a comprehensive suite of retail and commercial banking solutions across the United States. It serves a broad spectrum of clients, from individual consumers and small enterprises to large corporations and various institutions.

Score Breakdown

Growth
34.0/100
weight: 45%
Quality / Profitability
53.2/100
weight: 40%
Financial Health
43.9/100
weight: 15%
* Debt/equity and current ratio excluded: sector 'Financial Services' runs balance-sheet leverage (deposits, policy reserves) that these industrial-style thresholds aren't built for
* Revenue moved +40% between 2025-12-31 and 2026-03-31 (vs. -4% for the same quarter a year earlier) in its reported financials - possibly a divestiture, spinoff, or major acquisition rather than organic performance. Growth/trend comparisons spanning this point may be distorted.
Valuation Context (informational only — not part of the score)
Rich vs. its own history
Entry Timing (informational only — not part of the score)
Neutral

Live Market DataPrice updated: 3h ago

P/E (TTM)
15.3
Yield
2.57%
RSI (14)
49.6
vs SMA20
-0.69%
vs SMA50
-0.97%
vs SMA200
+10.59%
Analyst Target
$79
+11.3%
10 analysts
AI Theoretical Price
$74
+5.0%
as of 2026-08-27

AI Deep-Dive Analysis

Analysis as of 2026-08-27 - price/technical figures below reflect that date, not live market data

As of 2026-08-27, CFG trades at $70.18 (down 0.44% on the day), roughly 7% below its 52-week high of $75.33, with a 2.57% dividend yield. The Q2 2026 earnings beat and improving net interest margin have kept analyst sentiment positive, but the stock sits above its own 5-year valuation averages.

AI Sentiment:Bullish

As of 2026-08-27, analyst sentiment is constructive: 30 Buy ratings vs. 7 Hold and 1 Sell, a consensus price target of $79.33, and recent target raises from Cantor Fitzgerald ($84) and Argus ($80). Q2 2026 EPS of $1.30 beat consensus by about $0.05, net income rose 41% YoY, NIM ticked up to 3.17%, and credit metrics improved. The technicals show a modest pullback from the highs, but the fundamental narrative is one of accelerating earnings and successful wealth expansion.

Quarterly Trend

The EPS progression is clearly upward: Q1'25 $0.77, Q2'25 $0.92, Q3'25 $1.05, Q4'25 $1.12, Q1'26 $1.13, Q2'26 $1.30. Operating margin expanded from 18.4% in Q2'25 and 16.2% in Q1'25 to 21.5% in Q1'26 and 23.6% in Q2'26. Reported revenue is choppy - Q4'25 dropped to $2.16B from roughly $3.0-3.1B in adjacent quarters before rebounding to $3.03B in Q1'26 and $3.20B in Q2'26 - which looks like a classification/data artifact rather than an organic collapse. The underlying trend since late 2025 is inflecting upward: net income grew from $373M in Q1'25 to $587M in Q2'26.

Valuation Assessment

As of 2026-08-27, CFG's P/E TTM is 15.1x vs. its 5-year average of 11.7x, and P/S is 2.59x vs. 2.02x - rich versus its own history. The forward P/E is roughly 13.2x on consensus FY EPS of $5.31, which is more palatable but still above the historical norm. The 2.57% dividend yield and 1.13x price/book provide some support, but on trailing metrics this is not a cheap stock; the apparent cheapness rests on future earnings recovery, not current reported results.

Price vs. Earnings Playbook

At $70.18, the market is pricing in continued EPS growth and NIM normalization rather than stagnant earnings. The 15.1x TTM multiple only works if forward EPS reaches $5.30-plus and the multiple holds. If earnings meet the $5.31 consensus but the P/E reverts to its 5-year 11.7x average, the stock would be closer to $62; if NIM expansion to 3.30-3.50% by 2027 drives EPS above estimates, 14x+ is defensible. In short, the stock is paying up for a recovery that is underway but not complete - there is little margin for error in the rates/macro outlook.

Technical Picture

As of 2026-08-27, RSI(14) is 43.0 - neutral, not oversold. Price is 2.8% below its 20-day SMA and 1.6% below its 50-day SMA, but 10.6% above its 200-day SMA. That is a pullback within an uptrend or an early consolidation, not a breakdown. Entry-timing implication: no oversold bounce signal yet; the better technical setup would be a reclaim of the 20/50-day averages or a deeper test closer to the 200-day.

Macro Factors
  • Federal Reserve policy: cooler jobs and macro data have markets pricing rate cuts; CFG's NIM can still benefit from fixed-rate asset repricing, but faster cuts would pressure loan yields and could stall the Q4'26 NIM guidance of 3.22-3.27%.
  • Net interest margin recovery: NIM expanded 3 bps QoQ to 3.17% in Q2'26, and management projects 3.30-3.50% by Q4'27 - the central driver of the earnings thesis.
  • Commercial real estate: charge-offs and nonaccruals are currently low (net charge-offs 0.37%), but office and multi-family CRE remain a real tail risk for regional banks.
  • Deposit competition: private-bank spot deposits reached $17.8B and loans $9.7B in Q2'26, but sticky deposit betas could limit margin upside if rates fall.
  • Sector valuation and rotation: regional banks have outperformed the broader market and XLF over the past year; a group-wide de-rating could hit CFG harder given it already trades above its historical multiples.
Key Catalysts
  • Barclays Global Financial Services Conference on September 14, 2026 - management may update NIM, expense, and capital-return targets.
  • Q3 2026 earnings in mid-October 2026 - watch fee income, deposit beta, NIM progression, and 'Reimagine the Bank' efficiency milestones.
  • Continued NIM expansion toward 3.30-3.50% by late 2027, with CET1 staying above 10%, could support sustained buybacks ($225M in Q2'26).
  • Private Bank and Wealth momentum: the August 26, 2026 addition of a Tampa advisory team with >$1B in AUM builds higher-fee revenue scale.
Key Risks
  • Faster or larger Fed rate cuts could compress NIM before the positive repricing benefits fully flow through.
  • CRE credit deterioration, especially office and multi-family, could push charge-offs well above the current 0.37% level.
  • Valuation de-rating: at 15.1x TTM vs. a 5-year average of 11.7x, even a modest earnings miss could trigger meaningful multiple compression.
  • Execution risk: the 'Reimagine the Bank' program and private-bank integration may not deliver the projected $450M annualized pre-tax savings by late 2028.
Investment Thesis

As of 2026-08-27, CFG is a solid and improving regional bank - earnings are accelerating, margins are expanding, and credit is clean - but the stock already trades above its own historical multiples, and the deterministic framework still labels the fundamentals weak. The risk/reward is not compelling for a new position at $70.18; a more interesting entry would be after a pullback that resets the multiple closer to historical norms, or after Q3 2026 confirms the NIM trajectory.

AI Theoretical Price Methodology

Applied a justified forward P/E of ~14.0x (roughly a 2.3-turn premium to the 5-year average P/E of 11.7x, reflecting the improving NIM, fee growth, and buyback trajectory, but a discount to the current 15.1x TTM multiple) to consensus forward EPS of $5.311, yielding $74.35.

AI Lean: BearishConfidence: Low

AI Review of the Deterministic Score

Partially Agree

The deterministic score of 43.2 / Weak Fundamentals is, in my read, slightly too punitive: the model is fully backward-looking, and the revenue sequence contains an apparent reporting artifact around Q4'25 that distorts growth calculations. Q2'26's EPS beat, 41% net-income growth, 23.6% operating margin, 3.17% NIM, and low charge-offs all point to a cyclical upward inflection the formula cannot see. However, I would not jump two tiers: ROIC is only 4.3%, trailing ROE is 7%, and the stock is priced at a premium to its own history. I would put the fair fundamental score in the low-50s / Fair area - a meaningful but not massive adjustment - hence Partially Agree.

AI-generated analysis for informational purposes only, not financial advice.